Skip to content
Dose Brief
Menu

CoreAge Rx review

By Updated

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Brief Score94/100Grade ANo. 1 in our directory
Visit CoreAge Rx We may earn a commission through this link at no extra cost to you. It does not change our score.
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Coverage
US only; restrictions by state, confirmed at intake
Brand-name
Not confirmed

Prices checked against CoreAge Rx's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerStableprice stable— The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

CoreAge Rx in depth

CoreAge Rx's public offers do not agree on one starting price. The annual-plan landing page checked on October 6, 2026 lists semaglutide at $79 a month and tirzepatide at $129. Its footer says those starting prices are based on a 12-month plan paid in full. The difference between a monthly equivalent and a monthly bill matters here: at those rates, you would pay $948 or $1,548 upfront.

The main product pages separately advertise semaglutide from $99 and tirzepatide from $149 per month, alongside generic no-long-term-contract wording. The landing-page annual condition should not be silently applied to every offer on the main site, nor should the main site's generic wording erase the landing condition. Confirm which page's offer your intake leads to and get the total charge and renewal terms before paying.

The checked public pages describe no membership fee, free delivery and a price that does not increase with the prescribed dose. Those are useful terms, but starting-price language still needs to be matched to the plan available to you. A monthly checkout option and its total were not established in this source check.

CoreAge sells compounded GLP-1 treatment in these offers. Compounded medications are not FDA-approved finished products, and brand approval or trial results should not be treated as approval or proof for a specific compound. Before paying for a long supply, ask who will prescribe and verify the dispensing pharmacy so you know where the medication will come from.

The existing state information says restrictions can depend on the therapy and are confirmed during intake. The current pricing check does not establish nationwide availability or name the pharmacy for an individual prescription. Those questions matter before committing to a year.

This is most useful for someone already considering prepayment who can verify the complete offer. If paying month to month is important, our CoreAge Rx and Eden comparison breaks down the billing differences and what to confirm before enrolling. CoreAge ranks first on this site and referral links may earn a commission; that does not remove the obligation to show the starting-price and annual-payment conditions.

Sources we checked

Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

CoreAge Rx scored on our six Brief Score factors. See the methodology.

Price Stability97/100
Supply Reliability95/100
Transparency90/100
Access Breadth93/100
Clinical Oversight92/100
Track Record88/100

What we like

  • Offers compounded semaglutide and tirzepatide plans
  • Checked pages describe no separate membership fee and free shipping
  • Provider says the price does not rise with the prescribed dose

The caveats

  • The advertised starting rates require 12 months paid in full: $948 or $1,548 at the advertised rate
  • Main product pages show different starting prices; confirm which offer applies
  • A one-month checkout price, individual state eligibility and dispensing pharmacy need confirmation

The brief

Best for: People considering a full-year prepaid plan who can confirm the qualifying offer, upfront charge and state eligibility before paying. CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Ranked #1 of 546 providers we reviewed — compare with Eden, for comparison.

Before you decide

The questions readers ask next after reading about CoreAge Rx.

Closest here

The providers scoring nearest CoreAge Rx — read each current assessment before choosing care.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect CoreAge Rx's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on CoreAge Rx's site. Not medical advice; see our disclosure.

← Back to all rankings